Q4

INDOCO REMEDIES LTD.

INDOCOFY2607 May 2026

Revenue+6.8%

Net Profit+19.6%

OPM11.24%

P&L

Quarterly Consolidated

Revenue

+6.8%475.61

Expenditure

+7.0%504.31

Net Profit

+19.6%-23.68

NPM -4.98%+24.6%EPS ₹2.57-19.7%

vs Q3 FY26

Informational and educational content only. Not investment advice.